Systems and methods for delivery of a therapeutic agent

US11045390B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11045390-B2
Application numberUS-201916376387-A
CountryUS
Kind codeB2
Filing dateApr 5, 2019
Priority dateApr 6, 2018
Publication dateJun 29, 2021
Grant dateJun 29, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to nozzles for removing a preservative from a fluid comprising a therapeutic agent to an eye. More particularly, the nozzles disclosed herein may minimize patient exposure to preservative by rapidly and selectively removing a preservative from a solution comprising a therapeutic agent. An example nozzle may comprise a flow diverter which directs a flow path from a fluid inlet to a fluid outlet over a length longer than the distance from the inlet to the outlet. In some cases, the nozzle may comprise a preservative removing agent.

First claim

Opening claim text (preview).

What is claimed is: 1. A device for removing a preservative from a formulation comprising a therapeutic agent, the device comprising: a nozzle comprising: a fluid outlet; an inlet cap comprising one or more apertures, the one or more apertures in the inlet cap comprising a fluid inlet; a flow diverter, wherein the flow diverter is configured to limit a flow between the fluid inlet and the fluid outlet when the device is not in use, wherein the flow diverter is configured to divert regions of a fluid flow path in a plurality of different directions, a total distance along the fluid flow path through a matrix from the fluid inlet to the fluid outlet being longer than a distance along an axis from the fluid inlet to the fluid outlet; and the matrix disposed within the nozzle, wherein the matrix is configured to absorb at least 50 percent of the preservative from the formulation comprising the therapeutic agent and the preservative. 2. The device of claim 1 , further comprising an outlet cap comprising one or more apertures, the one or more apertures in the outlet cap comprising the fluid outlet, wherein the outlet cap has a hydraulic permeability less than 10 Darcy. 3. The device of claim 2 , wherein either of the inlet cap or the outlet cap comprises a screen or a mesh. 4. The device of claim 2 , wherein either of the inlet cap or the outlet cap comprises a filter, wherein the filter comprises a pore size of about 0.2 microns. 5. The device of claim 2 , wherein either of the inlet cap or the outlet cap is prewetted with the preservative. 6. The device of claim 2 , wherein the hydraulic permeability of the inlet cap or the outlet cap is about 0.1 Darcy. 7. The device of claim 2 , wherein a pore size of the one or more apertures in the inlet cap or the outlet cap is less than a particle size of the matrix. 8. The device of claim 7 , wherein a pore size of the one or more apertures in the inlet cap or the outlet cap is about 0.2 microns. 9. The device of claim 1 , wherein a first drop of the formulation from the device and a tenth drop of the formulation from the device comprise equal concentrations of the preservative to within 10%. 10. The device of claim 1 , wherein a drop of the formulation from the device dispensed on a first day and a second drop dispensed on a seventh day comprise equal concentrations of the preservative to within 10% at a drop rate of at least one drop per day. 11. The device of claim 1 , wherein the formulation is forced through the nozzle from the fluid inlet to the fluid outlet and wherein forcing the formulation through the nozzle removes the preservative from the formulation. 12. The device of claim 11 , wherein at least 50 percent of the preservative is removed from the formulation and wherein at least 50 percent of the therapeutic agent is retained. 13. The device of claim 11 , wherein the device further comprises a reservoir containing the formulation, and wherein the reservoir is configured to have an internal pressure which increases with increasing squeeze pressure exerted by a user to form a drop. 14. The device of claim 13 , wherein the squeeze pressure is within a range from 0.01 Atm to 0.5 Atm. 15. The device of claim 13 , wherein the internal pressure comprises a pressure within a range from 1 Atm to 5 Atm. 16. The device of claim 13 , wherein the drop is formed within a time defined by a range between 0.1 seconds and 10 seconds. 17. The device of claim 13 , wherein the drop comprises a volume defined by a range between 1 μL and 100 μL. 18. The device of claim 1 , wherein the inlet cap has a hydraulic permeability less than 10 Darcy. 19. The device of claim 1 , wherein the hydraulic permeability of the inlet cap is less than a hydraulic permeability of the matrix.

Assignees

Inventors

Classifications

  • Filters adapted for location in special places, e.g. pipe-lines, pumps, stop-cocks, (B01D35/05 takes precedence; {water pipe system filters E03B3/18, E03B7/07; dirt catchers in sewers E03F; filters or strainers for pipe-lines in general B08B, E03F; object or dirt catching devices in sinks or the like E03C1/26; suction strainers or filters for pumps F04B53/005, F04D29/70}) · CPC title

  • A61J1/1456Primary

    using liquid filters · CPC title

  • A61F9/0008Primary

    Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00) · CPC title

  • adapted to discharge drops · CPC title

  • Caps or cap-like covers with membranes, e.g. arranged to be pierced · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11045390B2 cover?
The present disclosure relates to nozzles for removing a preservative from a fluid comprising a therapeutic agent to an eye. More particularly, the nozzles disclosed herein may minimize patient exposure to preservative by rapidly and selectively removing a preservative from a solution comprising a therapeutic agent. An example nozzle may comprise a flow diverter which directs a flow path from a…
Who is the assignee on this patent?
Tearclear Corp, Univ Florida
What technology area does this patent fall under?
Primary CPC classification A61J1/1456. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).